HC Wainwright Analysts Boost Earnings Estimates for FDMT
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Equities research analysts at HC Wainwright increased their Q2 2025 earnings per share estimates for shares of 4D Molecular Therapeutics in a report released on Monday, May 12th. HC Wainwright analyst M. Caufield now anticipates that the company will earn ($0.89) per share for the quarter, […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Equities research analysts at HC Wainwright increased their Q2 2025 earnings per share estimates for shares of 4D Molecular Therapeutics in a report released on Monday, May 12th. HC Wainwright analyst M. Caufield now anticipates that the company will earn ($0.89) per share for the quarter, […]
